Not known Facts About copyright 1 MG-SEMAGLUTIDE
The demo obtained both equally its Main endpoints, with semaglutide 2.four mg demonstrating statistically substantial and superior advancements in liver fibrosis without worsening of steatohepatitis, and also resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH when compared to placebo.oneAssuming the above ment